MG
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
iShares MSCI South Africa ETF
EZA
$462M
| $237K | ﹤0.01% |
+3,500
| New | +$254K |
2026 Q1
0 quarters
|
|
852
DELISTED
Crinetics Pharmaceuticals
CRNX
| $236K | ﹤0.01% |
+6,503
| New | +$290K |
2026 Q1
0 quarters
|
|
853
Charles River Laboratories
CRL
$14.4B
| $236K | ﹤0.01% |
+1,369
| New | +$254K |
2026 Q1
0 quarters
|
|
854
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$597M
| $235K | ﹤0.01% |
+20,271
| New | +$247K |
2026 Q1
0 quarters
|
|
855
Addus HomeCare
ADUS
$2.18B
| $234K | ﹤0.01% |
+2,500
| New | +$265K |
2026 Q1
0 quarters
|
|
856
Cedar Fair
FUN
$915M
| $233K | ﹤0.01% |
13,134
| – | – |
2025 Q3
2 quarters
|
|
857
Expeditors International
EXPD
$25.5B
| $233K | ﹤0.01% |
+1,627
| New | +$247K |
2026 Q1
0 quarters
|
|
858
Arrowhead Research
ARWR
$8.25B
| $233K | ﹤0.01% |
3,714
-973
| -21% | -$61.6K |
2025 Q4
1 quarter
|
|
859
CPI Aerostructures
CVU
$66.2M
| $231K | ﹤0.01% |
+58,939
| New | +$244K |
2026 Q1
0 quarters
|
|
860
BellRing Brands
BRBR
$1.01B
| $231K | ﹤0.01% |
14,331
-3,090
| -18% | -$62.6K |
2024 Q4
5 quarters
|
|
861
Deere & Co
DE
$175B
| $230K | ﹤0.01% |
+409
| New | +$231K |
2026 Q1
0 quarters
|
|
862
O'Reilly Automotive
ORLY
$70.1B
| $230K | ﹤0.01% |
+2,490
| New | +$234K |
2026 Q1
0 quarters
|
|
863
Xsolla SPAC 1 Units
XSLLU
$256M
| $228K | ﹤0.01% |
+23,000
| New | +$228K |
2026 Q1
0 quarters
|
|
864
McDonald's
MCD
$169B
| $227K | ﹤0.01% |
730
-14
| -2% | -$4.46K |
2024 Q1
8 quarters
|
|
865
Tetra Tech
TTEK
$8.61B
| $227K | ﹤0.01% |
+7,526
| New | +$266K |
2026 Q1
0 quarters
|
|
866
Iron Mountain
IRM
$33B
| $226K | ﹤0.01% |
2,215
-832
| -27% | -$82.8K |
2025 Q4
1 quarter
|
|
867
Lyft
LYFT
$6.24B
| $226K | ﹤0.01% |
16,977
-139,280
| -89% | -$2.16M |
2025 Q3
2 quarters
|
|
868
Amkor Technology
AMKR
$11.1B
| $226K | ﹤0.01% |
+5,009
| New | +$240K |
2026 Q1
0 quarters
|
|
869
BlackRock Enhanced Global Dividend Trust
BOE
$646M
| $225K | ﹤0.01% |
20,519
+738
| +4% | +$8.62K |
2025 Q3
2 quarters
|
|
870
Clough Global Opportunities Fund
GLO
$231M
| $225K | ﹤0.01% |
40,359
+20,359
| +102% | +$119K |
2025 Q4
1 quarter
|
|
871
GDS Holdings
GDS
$5.18B
| $224K | ﹤0.01% |
5,564
-1,793
| -24% | -$76.9K |
2025 Q3
2 quarters
|
|
872
Ultragenyx Pharmaceutical
RARE
$1.47B
| $224K | ﹤0.01% |
10,699
+1,041
| +11% | +$23.4K |
2025 Q4
1 quarter
|
|
873
Laureate Education
LAUR
$5.43B
| $223K | ﹤0.01% |
+6,408
| New | +$219K |
2026 Q1
0 quarters
|
|
874
iShares MSCI Germany ETF
EWG
$1.42B
| $223K | ﹤0.01% |
+5,625
| New | +$238K |
2026 Q1
0 quarters
|
|
875
Commercial Metals
CMC
$7.22B
| $223K | ﹤0.01% |
+3,628
| New | +$262K |
2026 Q1
0 quarters
|
|
Similar funds
AF
NAM
ATO
DSA
A
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.